Vaccinal issues between Belgian and French travelers

Med Mal Infect. 2012 Nov;42(11):545-52. doi: 10.1016/j.medmal.2012.08.002. Epub 2012 Oct 15.

Abstract

Introduction: The yellow-fever vaccination center of the Tourcoing Hospital (France) has been accessible to Belgian travelers since its opening in 1994.

Method: The authors reported the specificities of these consultations during the year 2010, by retrospectively analyzing electronic medical records.

Results: Some medical issues encountered during the consultation were due to differences in vaccination schedules: for the polio vaccine, since the last dose is administered between 5 and 7 years of age in Belgium; and for the measles vaccine since a late two-dose schedule (second dose between 12 and 13 years of age) is recommended in this country. Moreover, some specific vaccines are available only in Belgium: a diphtheria-tetanus bivalent vaccine, and a live attenuated oral typhoid vaccine.

Discussion: The specificities of the Belgian border traveler consultation in our French yellow-fever center are due to a difference in European vaccination schedules; the physician must be aware of these.

Conclusion: The physician has to propose updates on vaccination schedules, and be aware of yellow-fever vaccine compatibility with vaccines recently administered in Belgium.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • BCG Vaccine
  • Belgium
  • Child
  • Child, Preschool
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Emigration and Immigration
  • Female
  • France
  • Health Policy
  • Humans
  • Immunization Schedule*
  • Immunization, Secondary
  • Infant
  • Male
  • Middle Aged
  • Practice Guidelines as Topic
  • Retrospective Studies
  • Travel*
  • Vaccination / statistics & numerical data*
  • Viral Vaccines
  • Young Adult

Substances

  • BCG Vaccine
  • Diphtheria-Tetanus-Pertussis Vaccine
  • Viral Vaccines